OR WAIT 15 SECS
Updated employee announcements, business news and recognition in the industry today.
as the company's Chief Operating Officer and President. In this newly created position, Powell will be responsible for all aspects of the company’s operational delivery including services and technology.
Eurofins Bioanalytical Services
Jennifer Ohayon, PhD
has joined the company as a Scientific Director for large molecule bioanalysis based at the company's St Charles, MO facility. Most recently, Ohayon was the Director of R&D at Davita Healthcare.
as its Senior Vice President, Sales and Marketing. Most recently, Hein was senior vice president of clinical research services at PRA Health.
announced it has welcomed its 20th annual class of recent graduates, onboarding 15 new employees from the class of 2016. In addition, recent internal promotions include
, previously engagement manager, was promoted to principal;
, formerly senior manager, moved in to the role of associate director;
, previously senior consultants, were promoted to engagement managers;
, former consultant, was promoted to senior manager.
, previously a consultant, was promoted to senior consultant.
Christian Dreger, PhD
, as Senior Vice President, PAREXEL Access and PAREXEL Consulting. Dreger joins PAREXEL from Biogen where he served as Vice President and Head of Global Commercial Operations, Biosimilars.
has appointed Jamie Moss as Chief Operating Officer (COO). Moss most recently he was Head of Engineering Capability for QinetiQ’s Air Division.
(WCGF)--a 501(c)(3) public charity that raises and distributes funds to give desperately ill patients expanded access to experimental treatments, and more in the clinical research industry--has appointed its board of directors, as follows: Chairman
Peter F. Buckley, MD
, of Medical College of Georgia at Augusta University (AU); Secretary
Alan Lefkowitz, JD
, of WIRB-Copernicus Group (WCG); Treasurer
David Farber, JD
, of King & Spalding;
Anita L. Allen, JD, PhD
, of the University of Pennsylvania;
Donald A. Deieso, PhD
, of WCG and Arsenal Capital Partners;
Kenneth A. Getz
of the Center for Information and Study on Clinical Research Participation (CISCRP) and Tufts University School of Medicine;
Stephen M. McLean
of Arsenal Capital Partners;
Lindsay McNair, MD
, of WCG, and
Joanne Waldstreicher, MD
, of Johnson & Johnson.
Venn Life Sciences
as Chairman to the Board, replacing Tony Richardson who had been acting as Executive Chairman since January 2016.
CTI Clinical Trial and Consulting announced its latest appointments as follows:
Elias Anaissie, MD joins as Medical Director; Hyemi Cheon, Operations Manager, CTI Korea; Lisa Kaffenberger joins as Senior Travel Coordinator; Elizabeth Stanley, Research Associate, and Lorri Erhardt joins as Vice President, Clinical Monitoring. She most recently served as Executive Director, Global Head Clinical Site & Document Management at Astellas. The company also announced the following promotions: Brittany Donovan to Regulatory Specialist II; Brendan Doran, Manager, Research Pharmacy / Study Manager III; Alfredo Garcia to Senior Clinical Project Manager; Maria Izzo, Study Manager III; Mackenzie Pater to Study Manager II; Ashley Perry, Project Manager; and Yuhui Qiu to Biostatistician II.
to the newly created role of Executive Vice President, Operations Delivery.
announced the promotions of
Michael Gibertini, PhD
, to Chief Operating Officer (COO) succeeding Alistair Macdonald and
to President, Clinical Development Services. The appointments are being made in conjunction with the Company’s CEO succession plan with COO
assuming the role of Chief Executive Officer and joining the Board of Directors for INC Research effective Oct. 1, 2016. Alistair Macdonald succeeds Jamie Macdonald, who also has stepped down from the Board and will serve through Feb. 29, 2017, as Vice Chairman, reporting to the Chairman of the Board to assist with the transition.
as the company's Chief Operating Officer.
has been named a finalist for the 2016 Scrip Award in the Best Patient-Focused Technological Development in Clinical Trials, for its innovative electrocardiogram (ECG) / electronic Clinical Outcome Assessment (eCOA) integration.
announced that the first Certara Biomedical Research Scholarship has been awarded to the National Institutes of Health (NIH) National Center for Advancing Translational Science (NCATS) on behalf of postgraduate oncology research student David Morse, MPhil, and the research he is conducting in the laboratory of Craig Thomas, PhD. The
Duke Clinical Research Institute
(DCRI) has been named the coordinating center as part of a $157-millionm seven-year grant from the National Institutes of Health (NIH) for the Environmental Influences on Child Health Outcomes (ECHO) initiative.
was named a 2016 Best Place to Work by
Triangle Business Journal
, the fifth year the company has been honored with this award. Rho was also recently named to the
Triangle Business Journal
Fast 50 list, which recognizes the 50 fastest-growing private companies in the area.
was awarded Scale-Up Business of the Year, which recognizes entrepreneurial emergence on to the global stage as a CRO and Functional Service Provider (FSP). Founder and CEO Dr Rabinder Buttar was also honored as a finalist for Entrepreneur of the Year at the 5th Minority Supplier Development Network UK’s awards ceremony.
, a digital health startup that connects patients and researchers to accelerate medical research, has rebranded along with its new name: Antidote.
is celebrating 20 years in North America by announcing a $5.2 million investment and the creation of almost 80 new jobs across its Durham, North Carolina facilities. Almac first established presence in the US in 1996 with the opening of its clinical trial operations in Audubon, Pennsylvania.
Worldwide Clinical Trials
has opened a new office in the heart of Warsaw’s central business district, which will be home to 30-plus employees.
announced the 2016 team of
, who share inspiring, personal stories of life-changing clinical research and will compete in the company’s Ironman competition in late October. The PPD Heroes will share their motivating stories at the PPD Hero Awards, and the next day compete in the inaugural triathlon.
, together with the
Center for Information and Study on Clinical Research Participation (CISCRP)
, announced Team “C2: The Clinical Study Change Agent Collective” was chosen as the winner of the 2016
“Inspiring Hope” Ideathon
, for its idea to create a corporate social responsibility program to inform people about clinical trial participation.
Related Content:Online Extras